MedTrace Logo

Effects of Oral Probiotic Product on Vaginal Microbial Community and Parameters of Vaginal Health

NCT03543982 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 37

Last updated 2021-04-08

No results posted yet for this study

Summary

The purpose of the study is to assess the efficacy and safety of an oral probiotic product on the vaginal microbiome and on parameters of vaginal health. Eligible subjects will utilize the investigational product as directed for a period of 28 days. The vaginal microbial community and parameters of vaginal health will be measured at baseline and after 14 and 28 days of supplementation. A follow-up post-supplementation visit will be conducted on Day 42.

Conditions

  • Vaginal Health

Interventions

DIETARY_SUPPLEMENT

Oral probiotic product

Once per day (QD), 28 days

Sponsors & Collaborators

  • UAS Labs LLC

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-05-23
Primary Completion
2020-10-01
Completion
2021-03-18

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03543982 on ClinicalTrials.gov